These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 4234133)

  • 1. [Effect of Inacin capsule for eye disease].
    Fujinaga Y
    Nihon Ganka Kiyo; 1968 Mar; 19(3):462-7. PubMed ID: 4234133
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of iodo-niacin for retinal or vitreous hemorrhages and vitreous floaters.
    ABRAHAMSON IA; ABRAHAMSON IA
    Am J Ophthalmol; 1956 Nov; 42(5):771-2. PubMed ID: 13372702
    [No Abstract]   [Full Text] [Related]  

  • 3. The anticoagulant treatment of Eales' disease.
    Casanovas J; Castillo R
    Bibl Ophthalmol; 1968; 76():166-71. PubMed ID: 5674839
    [No Abstract]   [Full Text] [Related]  

  • 4. [Phonophoresis of fibrinolysin and potassium iodide in complex treatment of hemophthalmos].
    Grishutova LA
    Oftalmol Zh; 1979; 34(2):79-82. PubMed ID: 156901
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical experiences with pyridinolcarbamate in ophthalmology].
    Musini A; Fabbri G; Tancini G
    Ann Ottalmol Clin Ocul; 1969 Feb; 95(2):101-23. PubMed ID: 5398786
    [No Abstract]   [Full Text] [Related]  

  • 6. [Intravitreal urokinase for vitreous hemorrhage].
    Kolácek K
    Cesk Oftalmol; 1983 Jan; 39(1):29-32. PubMed ID: 6339087
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experience with anthocyanoside treatment of retinal haemorrhage during anticoagulant long-term therapy (author's transl)].
    Neumann L
    Klin Monbl Augenheilkd; 1973 Jul; 163(1):96-103. PubMed ID: 4750524
    [No Abstract]   [Full Text] [Related]  

  • 8. Potassiumiodide and vitreous opacities.
    HOUWER AW
    Ophthalmologica; 1946; 112(4-5):289-91. PubMed ID: 20293715
    [No Abstract]   [Full Text] [Related]  

  • 9. Total vitreous haemorrhage. A method of treatment.
    Forrester JV; Williamson J
    Trans Ophthalmol Soc U K (1962); 1974; 94(4):992-9. PubMed ID: 4534148
    [No Abstract]   [Full Text] [Related]  

  • 10. Symptomatic floaters as a clue to vitreoretinal disease.
    Morse PH
    Ann Ophthalmol; 1975 Jun; 7(6):865-8. PubMed ID: 1147515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of plasminogen activator (urokinase) in treatment of hemorrhage and thromboembolism of the eye].
    Gastaldi GM; Diotti G
    Minerva Oftalmol; 1969; 11(3):82-9. PubMed ID: 5406013
    [No Abstract]   [Full Text] [Related]  

  • 12. Intravitreal urokinase in the management of vitreous haemorrhage.
    Sellors PJ; Kanski JJ; Watson DM
    Trans Ophthalmol Soc U K (1962); 1974 Jul; 94(2):591-8. PubMed ID: 4534196
    [No Abstract]   [Full Text] [Related]  

  • 13. Intravitreal urokinase in the treatment of vitreous haemorrhage.
    Cleary PE; Davies EW; Shilling JS; Hamilton AM
    Trans Ophthalmol Soc U K (1962); 1974 Jul; 94(2):587-90. PubMed ID: 4534195
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical and experimental results of the treatment of some ocular diseases with desferrioxamine B].
    Campana G; Boschi MC
    Ann Ottalmol Clin Ocul; 1969 Mar; 95(3):200-24. PubMed ID: 5401431
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of chymotrypsin for intraocular hemorrhages].
    Palamarchuk GS; Khalina MD; Saĭfulina MG; Prilipko VV; Shpakovskaia GA
    Oftalmol Zh; 1972; 27(5):323-7. PubMed ID: 4656515
    [No Abstract]   [Full Text] [Related]  

  • 16. [The effect of fibrinolysin on the blood in the vitreous body].
    Rapis EG; Viatskikh V; Kalancha Sh
    Oftalmol Zh; 1969; 24(3):221-3. PubMed ID: 4241043
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical experience with niacinamide hydroiodide in ophthalmology].
    Fukunaga K; Kurimoto S
    Ganka; 1970 Jan; 12(1):67-71. PubMed ID: 4244068
    [No Abstract]   [Full Text] [Related]  

  • 18. [Subconjunctival injection of urokinase in the treatment of diabetic vitreous hemorrhage].
    Chen XL
    Zhonghua Yan Ke Za Zhi; 1983 Jan; 19(1):35-6. PubMed ID: 6406190
    [No Abstract]   [Full Text] [Related]  

  • 19. [Our experience in using collalysine].
    Pavlenko OA
    Oftalmol Zh; 1986; (3):188. PubMed ID: 3014411
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term management of symptoms of cerebral arteriosclerosis.
    Stern FH
    Geriatrics; 1971 Jul; 26(7):98-103. PubMed ID: 4253476
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.